BENERVA 250 mg, coated tablet 40 tablets, CIP 3400930256619
Active ingredients: Thiamine hydrochloride
Commercialized according to BDPM
Coated tablet40 tablets, CIP 3400930256619orale
No current ANSM shortage notice is included
Package details
Original BDPM fields are shown in French.
- Official name
- BENERVA 250 mg, comprimé enrobé
- Pharmaceutical form
- comprimé enrobé
- Route of administration
- orale
- Presentation description
- plaquette(s) PVC PVDC aluminium de 40 comprimé(s)
- Marketing authorisation holder
- TEOFARMA
- Reimbursement according to BDPM
- —
- Approval for use in healthcare institutions
- non
- Commercialization declaration date
- 12 Jun 2023
- Enhanced ANSM monitoring
- No
BDPM identifiers
CIS
66676755CIP73025661CIP133400930256619Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| CHLORHYDRATE DE THIAMINEcomprimé | 250,000 mg · un comprimé | SA |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Other packages of this medicine
The same medicine in another pack size, according to BDPM.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.
The current BDPM data does not list similar medicines for this product.